In vitro interleukin 12 activation of peripheral blood CD3+ CD56+ and CD3+ CD56- γδ T cells from glioblastoma patients

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 633-643

  Fujimiya, Yoshiaki ^a   Suzuki, Youichi ^a   Katakura, Ryuichi ^a   Miyagi, Taeko ^a   Yamaguchi, Tomohiro ^a   Yoshimoto, Takashi ^b   Ebina, Takusaburo ^a  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; BRAIN NEOPLASMS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; DRUG SYNERGISM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; REFERENCE VALUES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031005628     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 14C-labelled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest., 63: 162-170, 1990.
2. Hvas, J., Oksenberg, J. R., Fernando, R., Steinman, L., and Bernard, C. C. A. γδ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol., 46: 225-234, 1993.
3. Sitnissen, P., Vandevyver, C., Medaer, R., Vandegaer, L., Nies, J., Tuyls, L., Hafler, D. A., Raus, J., and Zhang, J. Increased frequency of γδ T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis: reactivity, cytotoxicity and T cell receptor V gene rearrangement. J. Immunol., 154: 4883-4894, 1995.
4. Burger, P. C., Vogel, F. S., Green, S. B., and Strike, T. A. Glioblastoma multiform and anaplastic implications. Cancer (Phila.), 56: 1106-1112, 1985.
5. Mahaley, M. S., Mattlin, C., Natarajan, N., Laws, E. R., and Peace, B. B. National survey of patterns of care for brain-tumor patients. J. Neurosurg., 71: 826-836, 1990.
6. Hayes, R. L., Koslow, M., Hiesiger, E. M., Hymes, K. B., Hochster, H., Moor, E. J., Pierz, D. M., Chen, D. K., Budzilovich, G. N., and Ransohoff, J. Improved long term survival after intracavity interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. Cancer (Phila.), 76: 840-852, 1995.
7. Mitropoulos, D., Kooi, S., Rodriguez-Villanueva, J., and Platsoucas, C. D. Characterization of fresh (uncultured) tumor-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin. Exp. Immunol., 97: 321-327, 1994.
8. Bachelez, H., Flagueul, B., Degos, L., Boumsell, L., and Bensussan, A. TCR γδ bearing T lymphocytes infiltrating human primary cutaneous melanomas. J. Invest. Dermatol., 98: 369-374, 1992.
9. Ferrarini, M., Pupa, S. M., and Zocchi, M. R. Distinct pattern of HSP72 and monomeric lamin receptor expression in human lung cancers infiltrated by γδ T lymphocytes. Int. J. Cancer, 57:486-490, 1994.
10. Kitayama, J., Atomi, Y., Nagawa, H., Kuroda, A., Mutoh, T., Minami, M-, and Juji, T. Function analysis of TCRγδ+ T cells in tumor-infiltrating lymphocytes (TIL) of human pancreatic cancer. Clin. Exp. Immunol., 93: 442-447, 1993.
11. Kabelitz, D. Role of γδ T cells in the immune response against tumor cells. Cancer J., 8: 190-194, 1995.
12. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf, S. F., and Trinchieri, G. Production of natural killer cells stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med., 776: 1387-1398, 1992.
13. + T lymphocytes, and NK cells. J. Immunol., 149: 3495-3502, 1992.
14. Soiffer, R. J., Robertson, M. J., Murray, C., Cochran, K., and Ritz, J. Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood, 82: 2790-2796, 1993.
15. Chan, S. F., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., and Trinchieri, G. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med., 173: 869-879, 1991.
16. Chomczynski, P., and Sacci, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
17. Saiki, R. K., Scharf, S., Floona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnheim, N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Washington DC), 230: 1350-1354, 1985.
18. Ponte, P., Ng, S. Y., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human β-actin cDNA. Nucleic Acids Res., 12: 1687-1696, 1984.
19. Miescher, S., Stoeck, M., Qiao, L., Barras, C., Barrelet, L., and Von Fliedner, V. Proliferative and cytolytic potentials of purified human tumor-infiltrating lymphocytes: impaired response to mitogen-driven stimulation despite T cell receptor expression. Int. J. Cancer, 42: 659-666, 1988.
20. Alexander, J. P., Kudoh, S., Melsop, K. A., Hamilton, T. A., Edinger, M. G., Tubbs, R. R., Sica, D., Tuason, L., Klein, E., Bukowski, R. M., and Finke, J. H. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53: 1380-1387, 1993.
21. Vose, B. M., and Moor, M. Human tumor-infiltrating lymphocytes: a marker of host response. Semin. Hematol., 22: 27-40, 1985.
22. Yasumura, S., Lin, W-c., Hirabayashi, H., Vujanovic, N. L., Herberman, R. B., and Whiteside T. L. Immunotherapy of liver metas(tases of human gastric carcinoma with interleukin-2-activated natural 'killer cells. Cancer Res., 54: 3808-3816, 1994.
23. Soiffer, R. J., Murray, C., Shapiro, C., Collins, H., Chattier, S., Lazo, S., and Ritz, J. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin-2. Clin. Cancer Res., 2: 493-499, 1996.
24. Miescher, S., Stoeck, M., Qiao, L., Barrsas, C., Barrelet, L., and von Fliedner, V. Preferential clonogenic deficit of CDS-positive T-lymphocytes infiltrating human solid tumors. Cancer Res., 48: 6992-6998, 1988.
25. Haas, W., Pereira, P., and Tonegawa, S. γ/δ cells. Annu. Rev. Immunol., 11: 673-686, 1993.
26. Schild, H., Mavaddat, N., Litzenberger, C., Enrich, E. W., Davis, M. M., Bluestone, J. A., Matis, L., Draper, P. K., and Chien, Y. H. The nature of major histocompatibility complex recognition by γδ T cells. Cell, 76: 29-37, 1994.
27. Wolf, S. A., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferentz, C., Azzoni, L., Chan, S. H., Trinchieri, G., and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol., 146: 3074-3081, 1991.
28. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T., Donahue, C., Young, D., Hermann, S. H., and Ritz, J. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med., 175: 779-788, 1992.
29. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., and Caligiuri, M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-12 receptor. J. Exp. Med., 180: 1395-1403, 1994.
30. Chua, A. O., Chizzonite, R., Desai, B. B., Truitt, T. P., Nunes, P., Minetti, L. J., Warrier, R. P., Presky, D. H., Levine, J. F., Gately, M. K., and Gubler, U. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol., 153: 128-136, 1995.